Move positions company at the heart of Cambridge's innovation ecosystem to accelerate growth and collaboration in infection ...

For tried-and-true seafood, plus a few surprises, at a significant address. Today, Sewall is back in Kenmore all these years ...

In major cities across the country, return-to-office levels have hit new pandemic-era highs in the last few months. Here's ...

A major life science developer sold the aging mall at a loss to a new owner, who aims to keep it a hub for retail.

One alumni couple on why they’ve interviewed hundreds of MIT applicants—and keep in touch.

As a doctor, Peter Hsu treated vulnerable patients in hospitals across the country. Now in his second bid for City Council, ...

In September 2025, BXP, Inc. unveiled proposed changes to the next phase of its MXD District project in Cambridge's Kendall Square, introducing an option for two smaller commercial buildings and a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Netherlands biotech with a U ...

Twelve thousand international workers uphold Massachusetts’s booming technology and biotech industries — including more than 1,000 workers in Cambridge. But new fees on H-1B visas could soon cripple ...

In a look ahead at a week of Cambridge and Somerville events, there's a Monster Mash and you can meet the “Ghosts of ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...